420 related articles for article (PubMed ID: 16729734)
1. Quantum mechanics in structure-based drug design.
Peters MB; Raha K; Merz KM
Curr Opin Drug Discov Devel; 2006 May; 9(3):370-9. PubMed ID: 16729734
[TBL] [Abstract][Full Text] [Related]
2. The role of quantum mechanics in structure-based drug design.
Raha K; Peters MB; Wang B; Yu N; Wollacott AM; Westerhoff LM; Merz KM
Drug Discov Today; 2007 Sep; 12(17-18):725-31. PubMed ID: 17826685
[TBL] [Abstract][Full Text] [Related]
3. The application of quantum mechanics in structure-based drug design.
Mucs D; Bryce RA
Expert Opin Drug Discov; 2013 Mar; 8(3):263-76. PubMed ID: 23289945
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of H2-receptor histamine antagonists based on quantum chemical methods.
Luque FJ; Illas F; Pouplana R
Prog Clin Biol Res; 1989; 291():373-6. PubMed ID: 2567012
[No Abstract] [Full Text] [Related]
5. Quantum mechanics/molecular mechanics minimum free-energy path for accurate reaction energetics in solution and enzymes: sequential sampling and optimization on the potential of mean force surface.
Hu H; Lu Z; Parks JM; Burger SK; Yang W
J Chem Phys; 2008 Jan; 128(3):034105. PubMed ID: 18205486
[TBL] [Abstract][Full Text] [Related]
6. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
Rajamani R; Good AC
Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
[TBL] [Abstract][Full Text] [Related]
7. Quantum descriptors for biological macromolecules from linear-scaling electronic structure methods.
Khandogin J; York DM
Proteins; 2004 Sep; 56(4):724-37. PubMed ID: 15281126
[TBL] [Abstract][Full Text] [Related]
8. Computational methods to predict the reactivity of nanoparticles through structure-property relationships.
Poater A; Gallegos Saliner A; Solà M; Cavallo L; Worth AP
Expert Opin Drug Deliv; 2010 Mar; 7(3):295-305. PubMed ID: 20201736
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling of hydration in drug design.
Mancera RL
Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
[TBL] [Abstract][Full Text] [Related]
10. Modeling heme proteins using atomistic simulations.
Bikiel DE; Boechi L; Capece L; Crespo A; De Biase PM; Di Lella S; González Lebrero MC; Martí MA; Nadra AD; Perissinotti LL; Scherlis DA; Estrin DA
Phys Chem Chem Phys; 2006 Dec; 8(48):5611-28. PubMed ID: 17149482
[TBL] [Abstract][Full Text] [Related]
11. Physics-based methods for studying protein-ligand interactions.
Huang N; Jacobson MP
Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
[TBL] [Abstract][Full Text] [Related]
12. Combined quantum mechanics/molecular mechanics (QM/MM) methods in computational enzymology.
van der Kamp MW; Mulholland AJ
Biochemistry; 2013 Apr; 52(16):2708-28. PubMed ID: 23557014
[TBL] [Abstract][Full Text] [Related]
13. Development of quantitative structure-property relationships for predictive modeling and design of energetic materials.
Morrill JA; Byrd EF
J Mol Graph Model; 2008 Oct; 27(3):349-55. PubMed ID: 18653366
[TBL] [Abstract][Full Text] [Related]
14. Prediction of blood-brain partitioning: a model based on ab initio calculated quantum chemical descriptors.
Van Damme S; Langenaeker W; Bultinck P
J Mol Graph Model; 2008 Jun; 26(8):1223-36. PubMed ID: 18178493
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationship (QSAR) for a series of novel cannabinoid derivatives using descriptors derived from semi-empirical quantum-chemical calculations.
Ferreira AM; Krishnamurthy M; Moore BM; Finkelstein D; Bashford D
Bioorg Med Chem; 2009 Mar; 17(6):2598-606. PubMed ID: 19250829
[TBL] [Abstract][Full Text] [Related]
16. The Hydrogen-Bond: computational approaches and applications to drug design.
Rey S; Carrupt PA; Testa B
Ann Pharm Fr; 2002 Nov; 60(6):386-96. PubMed ID: 12514504
[TBL] [Abstract][Full Text] [Related]
17. Target-related applications of first principles quantum chemical methods in drug design.
Cavalli A; Carloni P; Recanatini M
Chem Rev; 2006 Sep; 106(9):3497-519. PubMed ID: 16967914
[No Abstract] [Full Text] [Related]
18. Modelling enzyme reaction mechanisms, specificity and catalysis.
Mulholland AJ
Drug Discov Today; 2005 Oct; 10(20):1393-402. PubMed ID: 16253878
[TBL] [Abstract][Full Text] [Related]
19. Computational enzymology: insight into biological catalysts from modelling.
van der Kamp MW; Mulholland AJ
Nat Prod Rep; 2008 Dec; 25(6):1001-14. PubMed ID: 19030602
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
